Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Gross Profit: 2020-2022

Historic Gross Profit for Therapeutics (RAPT) over the last 3 years, with Dec 2022 value amounting to $1.5 million.

  • Therapeutics' Gross Profit rose 1.96% to $886,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $3.2 million, marking a year-over-year decrease of 33.98%. This contributed to the annual value of $1.5 million for FY2022, which is 59.95% down from last year.
  • Per Therapeutics' latest filing, its Gross Profit stood at $1.5 million for FY2022, which was down 59.95% from $3.8 million recorded in FY2021.
  • Therapeutics' Gross Profit's 5-year high stood at $5.0 million during FY2020, with a 5-year trough of $1.5 million in FY2022.
  • Moreover, its 3-year median value for Gross Profit was $3.8 million (2021), whereas its average is $3.5 million.
  • Data for Therapeutics' Gross Profit shows a maximum YoY crashed of 59.95% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Therapeutics' Gross Profit stood at $5.0 million in 2020, then dropped by 24.38% to $3.8 million in 2021, then crashed by 59.95% to $1.5 million in 2022.